Quercetin protects against lipopolysaccharide-induced cardiac injury in mice.
- Author:
	        		
		        		
		        		
			        		Jian LI
			        		
			        		
			        		
			        			1
			        			,
			        		
			        			2
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Jian ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Xinmin DONG
			        		
			        		;
		        		
		        		
		        		
			        		Huafei DENG
			        		
			        		;
		        		
		        		
		        		
			        		Fan YANG
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Journal Article
 - MeSH: Animals; Cardiotonic Agents; pharmacology; Heart; drug effects; Lipopolysaccharides; adverse effects; Mice; Mice, Inbred C57BL; Myocardium; metabolism; Nitric Oxide Synthase Type II; metabolism; Nitric Oxide Synthase Type III; metabolism; Proto-Oncogene Proteins c-bcl-2; metabolism; Quercetin; pharmacology
 - From: Journal of Southern Medical University 2015;35(7):1068-1072
 - CountryChina
 - Language:Chinese
 - 
		        	Abstract:
			       	
			       		
				        
				        	
OBJECTIVETo evaluate the protective effect of quercetin against lipopolysaccharide (LPS)-induced cardiac injury in mice.
METHODSC57BL/6J mice were randomized into 4 groups to receive intraperitoneal injection of saline (negative control) or LPS (20 mg/kg), or fed with quercetin (100 mg/kg for 7 days) with or without subsequent LPS injection (quercetin+LPS group and quercetin control group, respectively). Six hour after LPS injection, the mice were tested for cardiac function with an echocardiograph, and the protein expressions of Bax, Bcl-2, iNOS, and eNOS in the myocardium were evaluated with Western blotting; serum NO concentration was also measured. The survival of the mice within 5 days after LPS injection was recorded to draw the survival curve.
RESULTSQuercetin pretreatment significantly improved the cardiac function of LPS-challenged mice (P<0.05), and attenuated LPS-induced increment in myocardial iNOS expression and decrement in eNOS level. LPS significantly increased the myocardial Bax expression and slightly decreased Bcl-2 expression; quercetin pretreatment decreased Bax expression to the control level and significantly lowered Bax/Bcl-2 ratio as compared with the LPS group. Serum NO level was significantly increased by nearly 2.5 folds in LPS-challenged mice, but was markedly decreased with quercetin pretreatment (P<0.05). The 5-day survival rate of LPS-treated mice was 10%, which was increased to 45% in quercetin- pretreated mice (P<0.05).
CONCLUSIONQuercetin can alleviate LPS-induced cardiac dysfunctions in mice to increase their survival rate following LPS challenge.
 
            